EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
24 11-2022

Save the date for the launch event of the RETHINKING Alzheimer’s disease White Paper!

2023-01-10T13:12:36+00:0024-11-2022|News|

The launch event of the RETHINKING Alzheimer's disease White Paper, calling for change in Alzheimer's care, will take place virtually on 24 January 2023 at 12:30 - 14:00. About Alzheimer's disease Alzheimer’s disease (AD) is a neurodegenerative disease that progresses in stages, beginning with a long silent phase before symptoms occur. It is the underlying cause [...]

10 11-2022

Launch event of the RETHINKING Alzheimer’s disease White Paper

2023-01-11T08:46:20+00:0010-11-2022|

The launch event of the RETHINKING Alzheimer’s disease White Paper, calling for change in Alzheimer’s care, will take place virtually on 24 January 2023 at 12:30 – 14:00. The European Brain Council (EBC), in collaboration with the European Federation of Pharmaceutical Industries and Associations (EFPIA), will present its White Paper “RETHINKING Alzheimer’s disease: Detection and diagnosis“. This paper is [...]

23 08-2022

Overcoming roadblocks: Making psychedelic-assisted therapy a reality

2022-08-23T09:47:27+00:0023-08-2022|

Learn about when and how psychedelic-assisted therapy becomes a reality. What are the legislative and regulatory roadblocks, and how Chris Koddermann (ITPRI - Reschedule Psilocybin), Amy Emerson (MAPS PBC), Tadeusz Hawrot (PAREA - Psychedelic Access and Research European Alliance) and Graham Pechenik (Calyx Law) are taking them down? When will psychedelic-assisted therapy become a reality [...]

Go to Top